Arteris Q1 FY2026: Revenue and EPS Beat, Guidance Raised

Arteris reported Q1 FY2026 revenue of $22.9 million, surpassing the street estimate of $21.0 million, representing a 9.1% surprise. The company's EPS came in at -$0.03, significantly better than the estimated -$0.08, resulting in a 62.5% surprise. This performance underscores the company's ability to execute against its strategic goals and capitalize on market opportunities.

The revenue beat was driven by strong demand across multiple segments, particularly in royalties and annual contract value (ACV). CFO Nicholas Bryan Hawkins highlighted the company's performance, stating, "Total revenue for the first quarter was $22.9 million up 39% year over year and above the top end of our guidance range." This year-over-year growth is a testament to Arteris's expanding customer base and the increasing adoption of its solutions.

Despite the revenue growth, Arteris's gross margin for the quarter was 83.0%, a significant decline from the 91.5% reported in Q1 FY2023. CFO Nicholas Bryan Hawkins noted, "Non GAAP gross profit in the quarter was $20.1 million representing a gross margin of 87%." The GAAP gross margin was 86%, reflecting the impact of non-recurring expenses and the company's strategic investments.

Operating expenses for the quarter were $22.6 million on a non-GAAP basis, in line with the company's operating leverage goals. CFO Hawkins explained, "In line with our operating leverage goals, we are maintaining our commitment to limit overall growth in OpEx to 50% of our revenue growth." The GAAP operating expense was $29 million, which included $600 thousand in acquisition-related expenses. The non-GAAP operating loss was $2.5 million, at the top end of the guidance range, while the GAAP operating loss was $9.3 million, compared to a loss of $7.7 million in the prior year period.

One of the key highlights of the quarter was the strong performance in trailing 12-month royalties, which reached $7.9 million, a 67% increase year over year. This growth in royalties is a direct result of the company's successful licensing agreements and the increasing adoption of its technology by customers.

The company's ACV plus royalties also saw significant growth, reaching $92.8 million, up 39% year over year. This strong performance in ACV plus royalties is a positive indicator of the company's future revenue potential and the strength of its customer relationships.

Arteris raised its full-year guidance for FY2026, reflecting the company's confidence in its business momentum. CFO Hawkins provided the updated guidance, stating, "For the full-year 2026, our guidance is as follows: ACV plus royalties to exit 2026 at $102 million to $106 million an increase of $2 million from prior guidance." The company now expects revenue of $91 million to $95 million, representing a 32% year-over-year increase at the midpoint. The non-GAAP operating loss is expected to be between $8.5 million and $4.5 million, an improvement of $500 thousand from prior guidance. Non-GAAP free cash flow is projected to be positive $5 million to positive $9 million.

The guidance raise is a clear indication of the company's strong execution and the positive market dynamics it is experiencing. CFO Hawkins emphasized, "We are seeing a strong start to the second quarter," which further supports the company's optimistic outlook.

Arteris ended the quarter with a strong balance sheet, with $41.9 million in cash, cash equivalents, and investments, and no financial debt. This solid financial position provides the company with the flexibility to invest in growth opportunities and maintain its strategic initiatives.

Free cash flow for the quarter was negative $7.4 million, which includes capital expenditures. Despite the negative free cash flow, the company's strong balance sheet and improved guidance for the full year suggest that it is well-positioned to achieve its financial goals.

The tone of the earnings call was notably positive, with a sentiment score of 0.45, a guidance tone of 0.34, and a tone confidence of 0.53. This represents a significant improvement from the previous quarter, with a call-over-call delta of +0.05 in sentiment, +0.15 in guidance tone, and +0.01 in tone confidence. CFO Hawkins's prepared remarks and the Q&A session both reflected a positive and optimistic tone, with a prepared sentiment score of 0.49 and a Q&A sentiment score of 0.49.

Full call-over-call delivery metrics are in the tone history.

The company's AI optimism score was 0.46, indicating a balanced and realistic outlook. The uncertainty score of 34.8, a significant decrease from the previous quarter, suggests that the company is providing clear and confident guidance. CFO Hawkins's comments on the strong start to the second quarter and the company's strategic goals further reinforced the positive tone of the call.

In the context of its peers in the EDA_IP subsector, Arteris's performance stands out. While the company's revenue growth of 39% year over year is strong, it is in line with the performance of some of its peers. For example, Synopsys [SNPS] reported a revenue of $2.276 billion with a 41.9% year-over-year growth, and ARM [ARM] reported a revenue of $1.490 billion with a 20.1% year-over-year growth. However, Arteris's gross margin of 83.0% is lower than the industry leaders like ARM, which reported a gross margin of 93.1%, and Cadence Design Systems [CDNS], which reported a gross margin of 95.8%.

Despite the lower gross margin, Arteris's strong revenue growth and positive guidance suggest that the company is well-positioned to continue its momentum. The company's focus on operating leverage and strategic investments is likely to drive further improvements in its financial performance.

Arteris does not have any notable customers or suppliers that are publicly traded. However, the company's strong performance in royalties and ACV suggests that it is benefiting from the broader semiconductor industry's growth. The increasing adoption of Arteris's solutions by customers in the aerospace and defense sector, as mentioned by CFO Hawkins, is a positive read-through for the company's future prospects.

Arteris's Q1 FY2026 results demonstrate the company's strong execution and market position. The revenue and EPS beat, combined with the raised full-year guidance, reflect the company's ability to capitalize on market opportunities and drive growth. The positive tone of the earnings call and the company's solid balance sheet further support the optimistic outlook. While the gross margin remains a point of focus, the company's strategic investments and operating leverage goals are likely to drive further improvements in its financial performance.

For investors, Arteris's strong Q1 FY2026 results and positive guidance provide a compelling case for continued investment in the company. The company's focus on growth and its strong market position make it a standout player in the EDA_IP subsector.